BHC News and Press, Bausch Health Companies Inc. From 11/02/23

Acushnet Holdings Corp. (GOLF) is expected to report $0.54 for Q3 2023 Paramount Global (PARA) is expected to report $0.09 for Q3 2023 Curis Inc. (CRIS) is expected to report $-2.32 for Q3 2023 Quanta Services Inc. (PWR) is expected to report $1.99 for Q3 2023 GRI Bio Inc. (GRI) i...

Bausch Health Companies Inc. (BHC) is expected to report $0.91 for Q3 2023

2023-11-01 15:21:44 ET More on Bausch Health Companies Bausch Health's Debt Dilemma: Strategic Decisions And Financial Metrics Bausch Health gains amid win in Norwich case over generic Xifaxan (update) Bausch Health gets FDA approval for acne treatment Cabtreo ...

LAVAL, QC / ACCESSWIRE / November 1, 2023 / Bausch Health Companies Inc. (NYSE:BHC)(TSX:BHC), and its gastroenterology business Salix Pharmaceuticals, Inc., today announced that the U.S. District Court for the District of Columbia in the matter of Norwich Pharmaceuticals, Inc. v. Becerra, et al...

2023-11-01 11:03:02 ET More on Bausch Health Companies Bausch Health's Debt Dilemma: Strategic Decisions And Financial Metrics Bausch Health Companies Inc. (BHC) Q2 2023 Earnings Call Transcript Bausch Health gets FDA approval for acne treatment Cabtreo Bausc...

2023-10-29 12:00:27 ET More on PBMs Cigna PBM unit Express Scripts sued for overcharging pharmacies FTC investigating purchasing organizations that work on behalf of PBMs Eli Lilly, Novo, Sanofi and leading PBMs accused in California over insulin prices CVS H...

2023-10-29 08:28:00 ET As the calendar turns from October to November, the week promises a flurry of earnings reports from some of the world's most prominent companies. Among the key players stepping into the earnings spotlight will be technology giant Apple ( NASDAQ: AAPL ), semico...

First-Ever Television Ad Campaign for APLENZIN ® (bupropion hydrobromide) Airs in October LAVAL, QC / ACCESSWIRE / October 26, 2023 / Bausch Health Companies Inc. (NYSE:BHC)(TSX:BHC) today announced the new release of "Looking Forward," the television ad campaign for APLENZIN ® (...

2023-10-20 17:41:42 ET More on Bausch Health Companies Bausch Health's Debt Dilemma: Strategic Decisions And Financial Metrics Bausch Health Companies Inc. (BHC) Q2 2023 Earnings Call Transcript Bausch Health Companies Inc. 2023 Q2 - Results - Earnings Call Presentat...

First and only FDA-approved fixed-dose, triple-combination topical treatment LAVAL, QC / ACCESSWIRE / October 20, 2023 / Bausch Health Companies Inc. (NYSE:BHC) (TSX:BHC) ("Bausch Health") and its dermatology business, Ortho Dermatologics, today announced that the U.S. Food and Drug Administ...